Clarity AD: A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease (clinicaltrials.gov) - Oct 7, 2026 - P3 | N=1906 | Active, not recruiting | Sponsor: Eisai Inc. | Trial completion date: Jun 2029 ➔ Dec 2026 | Trial primary completion date: Jun 2029 ➔ Dec 2026
Trial completion date • Trial primary completion date • Alzheimer's Disease • CNS Disorders
|